Le Lézard

Communiqués de presse par sujet : Santé

1 2 3 4 5 6 7 8 9 10

19 janvier 2019

08:00
National and international smoking cessation authorities are gathering in Ottawa today to attend the second and final day of the 11th Annual Ottawa Conference: State of the Art Clinical Approaches to Smoking Cessation, Canada's premier event...

08:00
Des experts du Canada et du monde entier se rassemblent à Ottawa aujourd'hui pour la deuxième et dernière journée de la 11e Conférence annuelle d'Ottawa : Approches cliniques : nouvelles tendances en matière d'abandon du tabac, source par excellence...


18 janvier 2019

11:55
The Ontario Health Coalition is releasing a new report, Situation Critical, on Monday, January 21 at 11:30 am. Situation Critical is a new report that examines government data to reveal the current shocking state of long-term care in Ontario. Among...

08:00
Des experts du Canada et du monde entier se rassemblent à Ottawa aujourd'hui dans le cadre de la 11e Conférence annuelle d'Ottawa : Approches cliniques : nouvelles tendances en matière d'abandon du tabac, source par excellence de nouvelles idées et...

08:00
National and international smoking cessation authorities are gathering in Ottawa today to attend the 11th Annual Ottawa Conference: State of the Art Clinical Approaches to Smoking Cessation, Canada's premier event promoting the latest ideas and...


17 janvier 2019

07:05
IMV Inc. , a clinical stage immuno-oncology corporation, today announced that the first patient has been treated in the Phase 1 trial evaluating neoepitopes formulated in the Company's proprietary DPX delivery platform in patients with ovarian...


16 janvier 2019

15:55
The American Botanical Council (ABC) announces the adoption of licorice (Glycyrrhiza spp., Fabaceae) by Natural Remedies, an herbal products research and development company, through ABC's Adopt-an-Herb program. With its adoption of licorice, Natural...

08:05
VBI Vaccines Inc. ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced the appointment of Blaine McKee, Ph.D., Executive Vice President and Chief Business...


15 janvier 2019

14:00
Nominations for the 14th annual Heart of Home Care Awards presented by VHA Home HealthCare (VHA) are now being accepted from across Ontario until January 31, 2019. The awards recognize the extraordinary efforts of individuals who have gone above and...

13:50
The ABC-AHP-NCNPR Botanical Adulterants Prevention Program (BAPP) has released a Botanical Adulterants Prevention Bulletin on ashwagandha (Withania somnifera) root and root extract. The powdered roots of ashwagandha, a member of the nightshade...

09:00
Integrated Cannabis Company, Inc. ("Integrated Cannabis"), is excited to announce that X-SPRAYStm successfully exhibited at the 2019 Athens Cannabis Expo in Greece last weekend at the Tae Kwon Do Convention Center in Athens, Greece. The Expo took...

08:00
Cotinga Pharmaceuticals Inc. ("Cotinga" or the "Company"), a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer, today announced that it has dosed the first patient with COTI-2 in combination...


14 janvier 2019

10:15
Translational Research In Oncology (TRIO), in collaboration with Novartis and under the direction of Dennis Slamon, MD, PhD, TRIO Chairman/Executive Director and Director of Clinical Translational Research at the University of California, Los Angeles...

09:00
FOR IMMEDIATE RELEASE ? January 13, 2019 ? Washington, D.C.  Access to Childhood Cancer Essentials (ACCESS) today announced two initiatives with partners across sectors to improve the lives of children with cancer in Africa. The first, in...

07:00
Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc.   (the "Company" or "Nash Pharma") is pleased to announce that in a new recent in vivo animal study for Chronic Kidney Disease (CKD), the activity of NP-135 was...

07:00
The Bladder Cancer Advocacy Network (BCAN) is pleased to announce our 2019 Young Investigator Awards (YIA), to support the development of outstanding, early career research scientists and clinical cancer research investigators who have demonstrated a...


11 janvier 2019

17:00
Any moves by the Ford government to privatize health care in Ontario would be a disaster for this province. Unless our government improves publicly funded and delivered health care, they are condemning Ontarians to painful choices when they are at...

17:00
Inspira Financial Inc. ("Inspira" or the "Company") announced the appointment of a Dr. Jaime Gerber as its Interim Chief Executive Officer. Dr. Jaime Gerber, the current Chairman of the Board of Inspira, has been appointed the new Interim Chief...

06:00
A delegation of concerned citizens from Sudbury and the surrounding area are traveling to North Bay to express their concerns at a press conference outside the office of Minister of Finance, Vic Fedeli with whom we have been requesting a meeting...


10 janvier 2019

09:50
A delegation of concerned citizens from Sudbury and the surrounding area are traveling to North Bay to express their concerns at a press conference outside the office of Minister of Finance, Vic Fedeli with whom we have been requesting a meeting...


9 janvier 2019

07:00
Auxly Cannabis Group Inc. (the "Company") is pleased to announce that, further to its previous releases, it has completed the acquisition of 80% of the outstanding common shares (the "Transaction") of Inverell S.A. ("Inverell"). The Transaction...

06:55
The Flowr Corporation , through its subsidiary The Flowr Group (Okanagan) Inc. (collectively "Flowr" or the "Company"), announced today that it has entered into an agreement to supply medical cannabis to Shoppers Drug Mart (Shoppers) on a purchase...


7 janvier 2019

22:00
Building on the recent launch of the world's first Healthabletm hearing technology, Livio® AI, Starkey Hearing Technologies announces the first-ever Fall Detection and Alert capability within a hearing aid, as well as Heart Rate Measurement and...

08:30
Checkpoint Therapeutics, Inc. ("Checkpoint") , a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that...

07:00
Keros Therapeutics, a company dedicated to the discovery and development of novel therapeutics for neuromuscular diseases, announced a $23 million Series B financing today. This investment, coupled with Series A in 2016, brings the company's total...


4 janvier 2019

17:55
ChemioCare USA Inc. ("ChemioCare" or the "Company"), a platform company focused on proprietary transdermal delivery today announced that its Adult Ondansetron 5-day adhesive transdermal patch will initiate development and be adapted for use in...


3 janvier 2019

16:05
Humanigen, Inc., (HGEN) ("Humanigen"), a biopharmaceutical company developing its portfolio of Humaneered®...

10:45
DiaMedica Therapeutics Inc. ("DiaMedica") announced today that the U.S. Food and Drug Administration ("FDA") has accepted DiaMedica's Investigational New Drug application ("IND") for the initiation of a Phase Ib clinical trial of DM199 in patients...

07:30
The first patient has been enrolled in a global Phase 3b study evaluating the efficacy and safety of extended interval dosing (EID; every six weeks) for natalizumab compared to standard interval dosing (SID) in patients with relapsing multiple...

02:30
Curium, a leading global player in Nuclear medicine, and Progenics Pharmaceuticals, Inc. , an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, today announced an exclusive agreement...


31 décembre 2018

08:00
Acasti Pharma Inc. ("Acasti or the "Company") , a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia...


20 décembre 2018

13:25
As the northern hemisphere welcomes its shortest day of the year, the remote Alaskan city of Utqiagvik welcomes physicians and medical staff for its newly-built regional hospital ? despite the area's critical housing shortage and its location 330...

08:05
VBI Vaccines Inc. (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced its plans for a Phase 2 clinical study evaluating VBI-1501, the company's prophylactic...


19 décembre 2018

08:30
Harvest Health & Recreation, Inc. (Harvest), a vertically integrated public cannabis company with one of the largest footprints in the United States and now listed publicly on the CSE in Canada , today added to its existing retail license award in...

08:00
Bacteria that is resistant to antibiotics most critically important to humans, has been found in pork from supermarket shelves in Brazil, Spain and Thailand. This is a symptom of the routine overuse of antibiotics propping up low-welfare practices in...


18 décembre 2018

08:30
Assure Holdings Corp. (the "Company" or "Assure") , a provider of intraoperative neuromonitoring services, has performed its first neuromonitoring case in the state of Michigan. The move into Michigan represents the fifth new state Assure has added...


17 décembre 2018

16:10
Emergent BioSolutions Inc. today announced that Health Canada has approved the company's New Drug Submission (NDS) for its anthrax vaccine, BioThrax® (Anthrax Vaccine Adsorbed). BioThrax is indicated for active immunization for the prevention of...

14:40
CellTrak, the provider of the industry's leading Care Delivery Management solution used for over 1 million home care visits each week across the US, Canada, and the UK, announced today a new thought leadership audio program for home care agency...

09:00
Protech Home Medical Corp. ("PHM" or the "Company") , a healthcare services company with operations in the U.S., is pleased to announce that it has closed the acquisitions of Riverside Medical, Inc. ("Riverside Medical") and Central Oxygen, Inc....

07:30
Alkermes plc and Biogen Inc.  today announced that Alkermes has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for diroximel fumarate (BIIB098), a novel oral fumarate in development for the treatment of...


13 décembre 2018

08:30
Khiron Life Sciences Corp. ("Khiron" or the "Company") , , , an integrated medical cannabis company with its core operations in Colombia, is pleased to announce that, further to press releases issued on August 7, 2018 and October 24, 2018, the...

05:00
As Canadian policymakers grapple with a potential national pharmacare program, we should learn from the United Kingdom, Australia and New Zealand where publicly-funded pharmacare schemes have resulted in reduced access to new drugs for patients, drug...

04:05
73% of tumor regressions and 80% of clinical responses were observed in a subpopulation defined by a clinical biomarker based on Baseline Tumor Burden All durable clinical responses continued beyond the one year of treatment, surpassing the...


12 décembre 2018

15:20
OnRamp BioInformatics, a genomics company focused on scientist-friendly bioinformatics software solutions, today announced they are working with Active Motif to improve accuracies in data analysis for ChIP-Seq experiments. OnRamp's flagship...


11 décembre 2018

14:00
Cowan Insurance Group is excited to announce the launch of Cowan Health?a new Health Support service, offered in partnership with Novus Health. A three-tier health navigation platform focusing on health literacy, Cowan Health helps employees regain...


10 décembre 2018

18:50
Golden Leaf Holdings Ltd. ("Golden Leaf" or the "Company") , a cannabis company with cultivation, production and retail operations built around recognized brands, today announced that Michael Crooke has decided to resign from our Board to focus on...

18:20
CERESPIR INCORPORATED, société pharmaceutique engagée dans la découverte et le développement de traitements modificateurs de la maladie pour le traitement des maladies neurodégénératives, et THE NATIONAL NEUROSCIENCE INSTITUTE ?...

09:00
CERESPIR INCORPORATED a pharmaceutical company engaged in the discovery and development of disease-modifying therapeutics for the treatment of neurodegenerative diseases, and THE NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE, a national and international...

07:00
Axsome Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced a positive outcome of the interim analysis for the ADVANCE-1 Phase 2/3...


7 décembre 2018

09:15
Restaurants Canada has just released a carefully curated list of the top food and dining trends you can expect to see at the 2019 RC Show, Canada's largest foodservice and hospitality trade event.The upcoming RC Show is leading the conversation...

1 2 3 4 5 6 7 8 9 10